FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081224 [Registered on: 24/02/2025] Trial Registered Prospectively
Last Modified On: 21/02/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmeceuitcal]  
Study Design  Other 
Public Title of Study   Study to check safety of products on human volunteers 
Scientific Title of Study   Evaluation of irritation potential of Skin Care formulations on healthy human subjects 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
D01-6Q02-G4-JR25; Version: 01; Dated: 08/01/2025  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pooja Yadav 
Designation  Principal Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  poojayadav@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pooja Yadav 
Designation  Principal Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra


MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  poojayadav@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mohit Lalvani 
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  mohit.CTRI@gmail.com  
 
Source of Monetary or Material Support  
Geenia International Pvt Ltd 6A, 2ND Floor Najafgarh Road, Karampura Industrial Area, Landmark: Near CTC Mall, Karampura Pin code New Delhi:-110015  
 
Primary Sponsor  
Name  Geenia International Pvt Ltd  
Address  6A, 2ND Floor Najafgarh Road, Karampura Industrial Area, Landmark: Near CTC Mall, Karampura Pin code New Delhi:-110015  
Type of Sponsor  Other [Non-government company ] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pooja Yadav  Mascot Spincontrol India Pvt. Ltd.   Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
Mumbai
MAHARASHTRA 
02243349191

poojayadav@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Having Healthy skin on studied anatomic unit 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Negative Control (0.9% Isotonic saline solution)   A single application of about 0.04ml of 0.9% Isotonic Saline, is applied under occlusion for 24hrs on the subjects back.The patch will keep as it is for 24 hours and removed after that.  
Comparator Agent  Positive Control (1% w/w SLS)  A single application of about 0.04ml of 1% SLS, prepared in distilled water is applied under occlusion for 24hrs on the subjects back. The patch will keep as it is for 24 hours and removed after that.  
Intervention  SPF 35 CREAM (HYALURONIC ACID+CERAMIDES)  A single application of about 0.04ml of product, is applied under occlusion for 24hrs on the subjects back. The patch will keep as it is for 24 hours and removed after that. 
Intervention  VITAMIN C SPF 50 MOISTURISER  A single application of about 0.04ml of product, is applied under occlusion for 24hrs on the subjects back. The patch will keep as it is for 24 hours and removed after that. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1) Healthy Human Subjects
2) Skin should be healthy on the studied anatomic unit  
 
ExclusionCriteria 
Details  1)For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
2)Having refused to give his/her assent by not signing the consent form.
3)Taking part in another study liable to interfere with this study.
4) Being diabetic.
5) Being asthmatic.
6) Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
7)Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin).
8) Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
9) Having undergone a surgery requiring a general anesthesia of more than one hour in the past 6 months.
10) Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Dermatological safety / Irritation potential on skin  Baseline,0 hrs,24 hrs and 7 days  
 
Secondary Outcome  
Outcome  TimePoints 
Nil  NA 
 
Target Sample Size   Total Sample Size="26"
Sample Size from India="26" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="9" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Objective: The objective of this study will be to evaluate the irritation potential on healthy human subjects of Skin Care Formulations

Duration of study: 8 days study

 

Kinetics: T0 (Evaluation of test sites by Dermatologist, Patch application) ,T1(Patch removal, Evaluation of test sites by Dermatologist ,T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal), T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases)

 

Population: 26 healthy subjects (13 males + 13 females) .

The test area is checked for erythema and oedema caused due to the products and compared with positive control

 
Close